Biogen Idec, Inc. (Massachusetts) Reports Third Quarter 2005 Results

October 27, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 26, 2005--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, today reported its third quarter 2005 results.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Biogen